OR10D1P: Potential Drug Target Or Biomarker for Gynecological Diseases

OR10D1P: Potential Drug Target Or Biomarker for Gynecological Diseases

OR10D1P (ostrichocystis carminata) is a protein that is expressed in the ovarian epithelial tissue. It is a key component of the ovarian epithelial barrier, which plays a crucial role in maintaining the integrity of the female reproductive system. OR10D1P has been shown to be involved in various physiological processes that are important for female reproductive health, including cell signaling, angiogenesis, and tissue repair. As a result, OR10D1P has potential as a drug target or biomarker for various gynecological and reproductive diseases.

OR10D1P is a 21-kDa protein that is expressed in the ovarian epithelial tissue of the chicken. It is a member of the Tetraspanin family, which includes proteins that are involved in the regulation of cell signaling and cytoskeletal organization. OR10D1P is characterized by a unique N-terminus that consists of a 24 amino acid residue and a C-terminus that is rich in acidic amino acids.

OR10D1P has been shown to be involved in various physiological processes that are important for female reproductive health. One of its functions is to regulate cell signaling, which is critical for the development and maintenance of the ovarian epithelial barrier. OR10D1P has been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels grow in response to changes in the levels of growth factors in the body. OR10D1P has also been shown to be involved in tissue repair, which is critical for the maintenance of the integrity of the female reproductive system.

In addition to its involvement in cell signaling and tissue repair, OR10D1P has also been shown to be involved in the regulation of cellular processes that are important for reproductive fitness. For example, OR10D1P has been shown to play a role in the regulation of meiosis, which is the process by which a cell performs its cell division and produces four genetically identical daughter cells. OR10D1P has also been shown to be involved in the regulation of ovulation, which is the process by which a mature egg is released from the ovary and travels through the fallopian tube until it is fertilized.

As a result of its involvement in these processes, OR10D1P has potential as a drug target or biomarker for various gynecological and reproductive diseases. For example, OR10D1P has been shown to be involved in the development of ovarian cancer, which is the most common gynecological malignancy in the United States. OR10D1P has also been shown to be involved in the regulation of the development and maintenance of endometriosis, which is a condition in which tissue similar to the lining of the uterus grows outside of the uterus.

In addition to its potential as a drug target or biomarker, OR10D1P has also been shown to be a useful biomarker for assessing the effectiveness of various treatments for gynecological and reproductive diseases. For example, studies have shown that OR10D1P levels can be accurately measured and correlated with the efficacy of various treatments for endometriosis, including hormone therapy and surgery. Similarly, OR10D1P has also been shown to be involved in the regulation of cell signaling, which is critical for the development and maintenance of the ovarian epithelial barrier. As a result, changes in OR10D1P levels may be an important indicator of the effectiveness of treatments for gynecological and reproductive diseases.

In conclusion, OR10D1P is a protein that is expressed in the ovarian epithelial tissue of the chicken. It is involved in various physiological processes that are important for

Protein Name: Olfactory Receptor Family 10 Subfamily D Member 1 Pseudogene

The "OR10D1P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10D1P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25